Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort

Sir,In a recent issue of Infectious Diseases, Calza et al. [1] presented an interesting retrospective study on HIV combined antiretroviral therapy (cART) simplification with lamivudine (3TC) + Prot...